Gandeeva and Moderna Enter into Cryo-EM Research Collaboration to Explore Protein Surface Structure at Atomic Resolution
»
Menu
Gandeeva Therapeutics is harnessing the power of artificial intelligence and cryogenic electron microscopy to create life-changing therapies.
From small molecules that induce protein proximity, to engineered antibodies, our platform breaks new ground to develop precision medicines for the most challenging diseases.
Harnessing the power of artificial intelligence and cryogenic electron microscopy to create life-changing therapies.
Gandeeva’s drug discovery platform is first-of-its-kind. We start by identifying the right protein interfaces to target, then use cutting-edge artificial intelligence and structural knowledge gleaned from the world’s most advanced imaging platform to develop superior therapies for patients.
Gandeeva is developing an innovative pipeline of proximity-inducing glues in oncology that are selective and can achieve therapeutic effects by modulation of protein interactions.
Our mission is to transform the lives of patients through the development of highly targeted, first-in-class therapeutics. Please contact us to explore opportunities for collaboration and licensing.
We are an agile, interactive team of structural biologists, computer scientists, medicinal chemists, biotechnology industry veterans, and business leaders working together to transform the landscape of precision drug design.
Gandeeva and Moderna Enter into Cryo-EM Research Collaboration to Explore Protein Surface Structure at Atomic Resolution
Gandeeva Therapeutics Announces Appointment of Dr. Brenda G. Cooperstone to its Board of Directors
We are seeking creative leaders, problem solvers, and curious innovators. Join our interdisciplinary team and build a meaningful and impactful career in drug development with us.
